secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcutis Biotherapeutics, Inc. (ARQT)
CIK:        0001787306
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001787306-23-000081
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcutis CFO Scott Burrows resigns; former CFO John Smither named interim CFO
----------------------------------------------------------------------------

- Scott Burrows resigns as CFO effective Aug 31, 2023 to pursue external opportunity; no disagreement with company.
- John Smither, Arcutis' first CFO (2019-2021), appointed interim CFO effective Aug 31, 2023.
- Smither has over 25 years pharma finance experience, including CFO roles at Kythera, Unity, Sienna, and interim CFO at Kite.
- Smither will serve as principal financial and accounting officer; compensation terms to be disclosed later.
- Company has commenced search for permanent CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787306/000178730623000081/0001787306-23-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787306/000178730623000081/arqt-20230815.htm
  HTML page:      https://secwatch.observer/filing/0001787306-23-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer